Correction of Morphofunctional Disorders With Asialoerythropoietin and Selective Inhibitor of Arginase II KUD975 in Cases of Ischemic Kidney Damage in the Experiment

Research Results in Pharmacology
doi 10.3897/rrpharmacology.4.31846
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pensoft Publishers

Related search

Correction of Morphofunctional Disorders of the Cardiovascular System With Asialized Erythropoietin and Arginase II Selective Inhibitors KUD 974 and KUD 259 in Experimental Preeclampsia

Research Results in Pharmacology
2020English

Approaches to Correction of Ischemic and Reperfusion Kidney Injuries in Experiment

Research Result Medicine and Pharmacy
2018English

Correction of Retinal Ischemic Injuries by Using Non-Selective Imidazoline Receptor Agonists in the Experiment

Research Results in Pharmacology
2019English

Transcriptomic Markers of Predisposition to Ischemic Damage of the Kidney in Patients With Cancer

Medical News of North Caucasus
Medicine
2015English

Lipocortin-1 Is an Endogenous Inhibitor of Ischemic Damage in the Rat Brain

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

Expression of Arginase II in Prostate Cancer

International Journal of Oncology
Cancer ResearchOncology
2008English

Correction of the Acid-Base Balance in the Presence of the Hypoxic-Ischemic Brain Damage in Newborns

Rossiyskiy Vestnik Perinatologii i Pediatrii
Child HealthPediatricsPerinatology
2018English

The Role of Morphofunctional Changes of the Uterus in the Development of Reproductive Disorders in Women With Adenomyosis

Scientific digest of association of obstetricians and gynecologists of Ukraine
2019English

The Possibilities of Non-Pharmacological Correction of Immunological Disorders in the Acute Period of Ischemic Stroke

Bulletin physiology and pathology of respiration
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy